Annual Tuberculosis Genotyping Update

Date: Wednesday, January, 15, 2020
Location: City University of New York (CUNY) Law School Auditorium, 2 Court Square, Long Island City, New York 11101

COURSE DESCRIPTION & OVERALL GOAL
The overall purpose of the annual NYC Genotyping Update Conference is to discuss advances in and applications of molecular methods for TB care, prevention, epidemiology and research. The conference will provide an opportunity to discuss current and emerging issues in Tuberculosis molecular testing.

AGENDA

For the final presentations from the conference, please see link below:
http://globaltb.njms.rutgers.edu/2020/NYCGenotyping2020.php

WHO SHOULD ATTEND
This conference is open to epidemiologists, laboratorians, clinicians, researchers, and TB program staff.

WHY COURSE IS NEEDED
The emergence of whole genome sequencing and other molecular tests for tuberculosis (TB) has the potential to transform both clinical and epidemiologic aspects of TB care and prevention. As these tests become more widespread, resources are needed to help orient clinicians and public health practitioners to these new methods, related processes and tools, and best practices for their application.

OBJECTIVES
Upon completion of this conference, participants should be better able to:

  • Define molecular based laboratory tests used for TB diagnosis and the detection of drug resistance
  • Compare laboratory test types used in the detection of TB drug resistance and the characterization of TB strains
  • Interpret laboratory tests results across multiple methods of detection of TB drug resistance
  • List methods for TB genotyping and the characterization of TB strains
  • Integrate whole genome sequencing results into routine outbreak detection, prioritization and investigation work
  • Interpret whole genome sequencing results – including phylogenetic trees and SNP distances – to identify and refute TB transmission
  • Recognize varied applications of the results generated by whole genome sequencing and other molecular laboratory tests for TB
  • Select data organization and visualization tools to assist with cluster investigations and related public health interventions

COURSE REQUIREMENTS
In order to meet the learning objectives and receive continuing education credits, participants are required to attend the one day course in-person or via webinar, and complete an evaluation form.

CONTINUING EDUCATION INFORMATION
http://jointaccreditation.org/sites/default/files/Jointly%20Accredited%20Provider%20TM.jpgIn support of improving patient care, this activity has been planned and implemented by Rutgers Biomedical and Health Sciences, New York City Department of Health and Mental Hygiene, and National Tuberculosis Controllers Association Society of Epidemiology in Tuberculosis Control. Rutgers Biomedical and Health Sciences is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

CME: Rutgers Biomedical and Health Sciences designates this live activity for a maximum of 4.75 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
CNE: This activity is awarded 4.75 contact hours (60 minute CH). Nurses should only claim those contact hours actually spent participating in the activity.

DISCLOSURE POLICY
All individuals who affect content of continuing education activities are required to disclose to the audience any real or apparent conflict of interest related to the activity. The activity faculty are further required to disclose discussion of off-label/investigational uses in their presentations. These disclosures will be made to the audience at the time of the activity.

REGISTRATION INFORMATION & FEE
There is no fee for this conference and lunch will be provided.

Conference Registration Page

Registration deadline is January 8, 2020. However, if you register and are unable to attend, please inform us as soon as possible so that others may be accommodated.

CANCELLATION INFORMATION
We reserve the right to close registration early or cancel late registrants due to limits on seating capacity.

FUNDING DISCLOSURE
Funding for this conference was made possible in part by the Centers for Disease Control and Prevention. The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services, nor does the mention of trade names, commercial practices, or organizations imply endorsement by the U.S. government.

If you require any special accommodation (dietary requirements and/or mobility assistance) for this activity or need additional information, please contact Olivia Dupont od94@njms.rutgers.edu.

FACULTY

Vincent Escuyer, PhD
Wadsworth Center 
New York State Department of Health

Maha Reda Farhat, MD, MSc
Assistant Professor of Biomedical Informatics
Harvard Medical School

Randal Fowler, PhD
Chief of Mycobacteriology
New York City Department of Health

Jillian Knorr, MPH
NYC Research Scientist

New York City Department of Health

Herns Modestil, BS
Laboratory Director
New York City Department of Health

Jamie Posey, PhD
Team Leader, Applied Research Team
Centers for Disease Control and Prevention

Caralee Caplan Shaw, MD
Research Assistant Professor
NYU Langone Health + Hospital/Bellevue

Kathyrn Stinebaugh, MGIS
Epidemiology
Minnesota Department of Health

Sarah Talarico. PhD
Epidemiologist
Centers of Disease Control and Prevention

Jennifer Wheeler, MPH
Epidemiologist
North Carolina Department of Health

PLANNING COMMITTEE

Shama Ahuja, PhD, MPH
Director, Office of Surveillance and Epi

New York City Department of Health

Rajita Bhavaraju, PhD, MPH
Deputy Director
Global Tuberculosis Institute

Jason Cummins, MPH
 TB Program Manager
 Tennessee Department of Health

Jillian Knorr, MPH
NYC Research Scientist
New York City Department of Health

Diana Nilsen, RN, MD
Director, Medical Affairs
New York City Department of Health

Douglas Proops, MD
Bureau of Tuberculosis Control
New York City Department of Health

Jeanne Sullivan Meissner, MPH
Team Lead, TB Outbreak & Detection
New York City Department of Health

Benjamin Silk, PhD, MPH
 Lead, Molecular Epidemiology
Center for Disease Control and Prevention